https://www.vax-before-travel.com/2025/05/08/dengue-vaccine-sales-increase-259
Takeda's QDENGA®'s Q4 FY2024 (April 2024-March 2025), Revenue was JPY 35.6 billion ($247,746,985 US), an increase of 259%.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.020(10.8%) |
Mkt cap ! $38.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 16.5¢ | $31.63K | 182.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 69059 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 85485 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |